Loading…

Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer

This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loade...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics 2019-10, Vol.11 (11), p.559
Main Authors: Shukla, Snehal K, Kulkarni, Nishant S, Chan, Amanda, Parvathaneni, Vineela, Farrales, Pamela, Muth, Aaron, Gupta, Vivek
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3
cites cdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3
container_end_page
container_issue 11
container_start_page 559
container_title Pharmaceutics
container_volume 11
creator Shukla, Snehal K
Kulkarni, Nishant S
Chan, Amanda
Parvathaneni, Vineela
Farrales, Pamela
Muth, Aaron
Gupta, Vivek
description This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment.
doi_str_mv 10.3390/pharmaceutics11110559
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_46b6bfc7d4f3493fb47416177968c295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_46b6bfc7d4f3493fb47416177968c295</doaj_id><sourcerecordid>2550227844</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</originalsourceid><addsrcrecordid>eNptkk1v1DAQhi0EolXpTwBF4sIl4K84MQekZVmg0iIOlLPlj_FuVkkcbKfS_ntctlQtYi5jz7zzaGY0CL0k-C1jEr-b9zqO2sKSe5tIMdw08gk6J1LKmkvKnj54n6HLlA64GGOkY_I5OmNECCJ5e478N8g-xLGf6s1k9ZyWQWdw1bafQwojVJ9g6G8gHqsfx5RhfF-tpmrjPdhcwtV1BJ1HmHK1mucYtN1Xeqf7KeXqY0kVt9aThfgCPfN6SHB55y_Qz8-b6_XXevv9y9V6ta1tg5tcU-Fa5zAlDqyltz9JQFOtjTOYlO6dBCepYxgwdN44YYiRHAxg0nWNYxfo6sR1QR_UHPtRx6MKuld_AiHulI5laQMoLoww3raOe8Yl84a3nAjStlJ0lsqmsD6cWPNiRnC2TBn18Aj6ODP1e7ULN0pIirtOFsCbO0AMvxZIWY19sjAMeoKwJEUZwUJ0raBF-vof6SEscSqrUrRpMKVtx3lRNSeVjSGlCP6-GYLV7WGo_x5GqXv1cJL7qr9nwH4DKf25sQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2550227844</pqid></control><display><type>article</type><title>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</title><source>NCBI_PubMed Central(免费)</source><source>Publicly Available Content (ProQuest)</source><creator>Shukla, Snehal K ; Kulkarni, Nishant S ; Chan, Amanda ; Parvathaneni, Vineela ; Farrales, Pamela ; Muth, Aaron ; Gupta, Vivek</creator><creatorcontrib>Shukla, Snehal K ; Kulkarni, Nishant S ; Chan, Amanda ; Parvathaneni, Vineela ; Farrales, Pamela ; Muth, Aaron ; Gupta, Vivek</creatorcontrib><description>This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment.</description><identifier>ISSN: 1999-4923</identifier><identifier>EISSN: 1999-4923</identifier><identifier>DOI: 10.3390/pharmaceutics11110559</identifier><identifier>PMID: 31661947</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>3d spheroids ; ampk activation ; Breast cancer ; Cancer therapies ; Chemotherapy ; Drug dosages ; Entrapment ; Homeostasis ; Hydration ; Kinases ; Lipids ; liposomes ; metformin</subject><ispartof>Pharmaceutics, 2019-10, Vol.11 (11), p.559</ispartof><rights>2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</citedby><cites>FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</cites><orcidid>0000-0002-3618-8178</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2550227844/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2550227844?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31661947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shukla, Snehal K</creatorcontrib><creatorcontrib>Kulkarni, Nishant S</creatorcontrib><creatorcontrib>Chan, Amanda</creatorcontrib><creatorcontrib>Parvathaneni, Vineela</creatorcontrib><creatorcontrib>Farrales, Pamela</creatorcontrib><creatorcontrib>Muth, Aaron</creatorcontrib><creatorcontrib>Gupta, Vivek</creatorcontrib><title>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</title><title>Pharmaceutics</title><addtitle>Pharmaceutics</addtitle><description>This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment.</description><subject>3d spheroids</subject><subject>ampk activation</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Drug dosages</subject><subject>Entrapment</subject><subject>Homeostasis</subject><subject>Hydration</subject><subject>Kinases</subject><subject>Lipids</subject><subject>liposomes</subject><subject>metformin</subject><issn>1999-4923</issn><issn>1999-4923</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1v1DAQhi0EolXpTwBF4sIl4K84MQekZVmg0iIOlLPlj_FuVkkcbKfS_ntctlQtYi5jz7zzaGY0CL0k-C1jEr-b9zqO2sKSe5tIMdw08gk6J1LKmkvKnj54n6HLlA64GGOkY_I5OmNECCJ5e478N8g-xLGf6s1k9ZyWQWdw1bafQwojVJ9g6G8gHqsfx5RhfF-tpmrjPdhcwtV1BJ1HmHK1mucYtN1Xeqf7KeXqY0kVt9aThfgCPfN6SHB55y_Qz8-b6_XXevv9y9V6ta1tg5tcU-Fa5zAlDqyltz9JQFOtjTOYlO6dBCepYxgwdN44YYiRHAxg0nWNYxfo6sR1QR_UHPtRx6MKuld_AiHulI5laQMoLoww3raOe8Yl84a3nAjStlJ0lsqmsD6cWPNiRnC2TBn18Aj6ODP1e7ULN0pIirtOFsCbO0AMvxZIWY19sjAMeoKwJEUZwUJ0raBF-vof6SEscSqrUrRpMKVtx3lRNSeVjSGlCP6-GYLV7WGo_x5GqXv1cJL7qr9nwH4DKf25sQ</recordid><startdate>20191028</startdate><enddate>20191028</enddate><creator>Shukla, Snehal K</creator><creator>Kulkarni, Nishant S</creator><creator>Chan, Amanda</creator><creator>Parvathaneni, Vineela</creator><creator>Farrales, Pamela</creator><creator>Muth, Aaron</creator><creator>Gupta, Vivek</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3618-8178</orcidid></search><sort><creationdate>20191028</creationdate><title>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</title><author>Shukla, Snehal K ; Kulkarni, Nishant S ; Chan, Amanda ; Parvathaneni, Vineela ; Farrales, Pamela ; Muth, Aaron ; Gupta, Vivek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>3d spheroids</topic><topic>ampk activation</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Drug dosages</topic><topic>Entrapment</topic><topic>Homeostasis</topic><topic>Hydration</topic><topic>Kinases</topic><topic>Lipids</topic><topic>liposomes</topic><topic>metformin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shukla, Snehal K</creatorcontrib><creatorcontrib>Kulkarni, Nishant S</creatorcontrib><creatorcontrib>Chan, Amanda</creatorcontrib><creatorcontrib>Parvathaneni, Vineela</creatorcontrib><creatorcontrib>Farrales, Pamela</creatorcontrib><creatorcontrib>Muth, Aaron</creatorcontrib><creatorcontrib>Gupta, Vivek</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shukla, Snehal K</au><au>Kulkarni, Nishant S</au><au>Chan, Amanda</au><au>Parvathaneni, Vineela</au><au>Farrales, Pamela</au><au>Muth, Aaron</au><au>Gupta, Vivek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer</atitle><jtitle>Pharmaceutics</jtitle><addtitle>Pharmaceutics</addtitle><date>2019-10-28</date><risdate>2019</risdate><volume>11</volume><issue>11</issue><spage>559</spage><pages>559-</pages><issn>1999-4923</issn><eissn>1999-4923</eissn><abstract>This study aimed at developing metformin hydrochloride (Met) encapsulated liposomal vesicles for enhanced therapeutic outcomes at reduced doses against breast cancer. Liposomal Met was prepared using thin-film hydration through various loading methods; passive loading, active loading, and drug-loaded lipid film. The drug-loaded film method exhibited maximum entrapment efficiency (~65%) as compared to active loading (~25%) and passive loading (~5%) prepared Met-loaded liposomes. The therapeutic efficacy of these optimized liposomes was evaluated for cellular uptake, cytotoxicity, inhibition of metastatic activity, and apoptosis-inducing activity. Results demonstrated significantly superior activity of positively charged liposomes resulting in reduced IC values, minimal cell migration activity, reduced colony formation, and profound apoptosis-induced activity in breast cancer cells as compared to Met. The anti-tumor activity was investigated using a clinically relevant in vitro tumor simulation model, which confirmed enhanced anti-tumorigenic property of liposomal Met over Met itself. To the authors' knowledge, this is the first report of Met-loaded liposomes for improving the efficacy and therapeutic effect of Met against breast cancer. With the results obtained, it can be speculated that liposomal encapsulation of metformin offers a potentially promising and convenient approach for enhanced efficacy and bioavailability in breast cancer treatment.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>31661947</pmid><doi>10.3390/pharmaceutics11110559</doi><orcidid>https://orcid.org/0000-0002-3618-8178</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1999-4923
ispartof Pharmaceutics, 2019-10, Vol.11 (11), p.559
issn 1999-4923
1999-4923
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_46b6bfc7d4f3493fb47416177968c295
source NCBI_PubMed Central(免费); Publicly Available Content (ProQuest)
subjects 3d spheroids
ampk activation
Breast cancer
Cancer therapies
Chemotherapy
Drug dosages
Entrapment
Homeostasis
Hydration
Kinases
Lipids
liposomes
metformin
title Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A53%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metformin-Encapsulated%20Liposome%20Delivery%20System:%20An%20Effective%20Treatment%20Approach%20against%20Breast%20Cancer&rft.jtitle=Pharmaceutics&rft.au=Shukla,%20Snehal%20K&rft.date=2019-10-28&rft.volume=11&rft.issue=11&rft.spage=559&rft.pages=559-&rft.issn=1999-4923&rft.eissn=1999-4923&rft_id=info:doi/10.3390/pharmaceutics11110559&rft_dat=%3Cproquest_doaj_%3E2550227844%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c505t-26d7dd021decc226d791ea2aabdb01318d9ed92d30e0e8fbd6b1b94ebe01885d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2550227844&rft_id=info:pmid/31661947&rfr_iscdi=true